Decreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-beta1.

T A McCaffrey, Harry L. Bush|Journal of Clinical Investigation|1995

Cited by 170